Akebia Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.About AKBA
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders.
CEOJohn P. Butler
CEOJohn P. Butler
Employees181
Employees181
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2007
Founded2007
Employees181
Employees181
AKBA Key Statistics
Market cap412.91M
Market cap412.91M
Price-Earnings ratio-21.16
Price-Earnings ratio-21.16
Dividend yield—
Dividend yield—
Average volume2.90M
Average volume2.90M
High today$1.63
High today$1.63
Low today$1.55
Low today$1.55
Open price$1.62
Open price$1.62
Volume2.53M
Volume2.53M
52 Week high$4.08
52 Week high$4.08
52 Week low$1.45
52 Week low$1.45
Stock Snapshot
With a market cap of 412.91M, Akebia Therapeutics(AKBA) trades at $1.58. The stock has a price-to-earnings ratio of -21.16.
During the trading session on 2026-01-02, Akebia Therapeutics(AKBA) shares reached a daily high of $1.63 and a low of $1.55. At a current price of $1.58, the stock is +1.9% higher than the low and still -3.1% under the high.
Trading activity shows a volume of 2.53M, compared to an average daily volume of 2.9M.
Over the past 52 weeks, Akebia Therapeutics(AKBA) stock has traded between a high of $4.08 and a low of $1.45.
Over the past 52 weeks, Akebia Therapeutics(AKBA) stock has traded between a high of $4.08 and a low of $1.45.
People also own
Based on the portfolios of people who own AKBA. This list is generated using Robinhood data, and it’s not a recommendation.